Reilly Financial Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-160
| Closed | -$35K | – | 1111 |
|
|
2021
Q1 | $35K | Buy |
160
+100
| +167% | +$18.8K | ﹤0.01% | 430 |
|
|
2020
Q4 | $7K | Hold |
60
| – | – | ﹤0.01% | 681 |
|
|
2020
Q3 | $6K | Hold |
60
| – | – | ﹤0.01% | 659 |
|
|
2020
Q2 | $7K | Hold |
60
| – | – | ﹤0.01% | 667 |
|
|
2020
Q1 | $5K | Buy |
60
+40
| +200% | +$4.24K | ﹤0.01% | 697 |
|
|
2019
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 829 |
|
|
2019
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 841 |
|
|
2019
Q2 | $3K | Hold |
20
| – | – | ﹤0.01% | 853 |
|
|
2019
Q1 | $3K | Sell |
20
-40
| -67% | -$5.95K | ﹤0.01% | 873 |
|
|
2018
Q4 | $6K | Hold |
60
| – | – | ﹤0.01% | 738 |
|
|
2018
Q3 | $10K | Hold |
60
| – | – | ﹤0.01% | 712 |
|
|
2018
Q2 | $8K | Hold |
60
| – | – | ﹤0.01% | 736 |
|
|
2018
Q1 | $7K | Buy |
60
+40
| +200% | +$5.03K | ﹤0.01% | 729 |
|
|
2017
Q4 | $3K | Hold |
20
| – | – | ﹤0.01% | 865 |
|
|
2017
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 918 |
|
|
2017
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 888 |
|
|
2017
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 861 |
|
|
2016
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 775 |
|
|
2016
Q3 | $3K | Buy |
+20
| New | +$1.91K | ﹤0.01% | 728 |
|
|
2014
Q3 | – | Sell |
-50
| Closed | -$5K | – | 866 |
|
|
2014
Q2 | $5K | Buy |
+50
| New | +$3.48K | ﹤0.01% | 682 |
|
Other funds holding GWPH
Reilly Financial Advisors's GWPH Position: Q2 2021 in Review
Reilly Financial Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 160 shares — an estimated $35K sold.
Reilly Financial Advisors first reported a position in GWPH in Q2 2014 and held it in 20 quarters. The position peaked at $35K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Reilly Financial Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Reilly Financial Advisors sold 160 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $35K.
- Reilly Financial Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 20 quarters.
- Reilly Financial Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $35K in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Reilly Financial Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.